Q&A

Challenges & Trends In Stem Cell-Derived Extracellular Vesicle Bioprocessing

Source: Eppendorf SE
Exosomes GettyImages-1078208498

Exosomes derived from mesenchymal stem cells (MSC) are a novel and trending alternative to restoring tissues and organs, avoiding the limitations typically associated with stem cell therapy. According to Pubmed, the number of citations on exosome research has grown more than ten times in the last decade! Application scientist, Dr. Jorge Escobar Ivirico, explains and underscores the key differences with the production of exosomes from other cellular therapies.

Originally published by Cell & Gene Therapy Insights

access the Q&A!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Eppendorf SE